Mersana Therapeutics Inc. ; Day Range - ; 52 Wk Range - ; Volume, M ; Market Value, $M ; EPS (TTM), -$ The 6 analysts with month price forecasts for MRSN stock have an average target of , with a low estimate of and a high estimate of The average. Discover Mersana Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. Mersana Therapeutics Inc (MRSN) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.
Track Mersana Therapeutics Inc (MRSN) Stock Price, Quote, latest community messages, chart, news and other stock related information. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Bid Price and Ask Price. The bid & ask refers to the price that an. MRSN | Complete Mersana Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. MERSANA THERAP. DL-, (0M4.F) stock forecast and price target · kondulaynen.runa Therapeutics, Inc. (%). At close: PM · Recommendation. Mersana Therapeutics (MRSN) stock price prediction is 0 USD. The Mersana Therapeutics stock forecast is 0 USD for September 08, Monday with technical. Mersana Therapeutics Inc. ; Next Fiscal Year Estimate, ; Median PE on Next FY Estimate, N/A ; High, $ ; Median, $ ; Low, $ The average price target is $ with a high estimate of $8 and a low estimate of $3. Sign in to your SmartPortfolio to see more analyst recommendations. Find the latest Mersana Therapeutics, Inc. (MRSN) stock quote, history, news and other vital information to help you with your stock trading and investing. Mersana Therapeutics Inc has % upside potential, based on the analysts' average price target. future price: according to them, MRSN price has a max estimate of USD and a min estimate of USD. Watch MRSN chart and read a more detailed Mersana. The average one-year price target for Mersana Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price.
According to analysts, MRSN price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Find the latest Mersana Therapeutics, Inc. (MRSN) stock quote, history, news and other vital information to help you with your stock trading and investing. Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 06 Sep, On average, Wall Street analysts predict that Mersana Therapeutics's share price could reach $ by Aug 27, The average Mersana Therapeutics stock price. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mersana Therapeutics. Mersana Therapeutics Stock Prediction In , the Mersana Therapeutics stock will reach $ if it maintains its current year average growth rate. According to the 8 analysts' twelve-month price targets for Mersana Therapeutics, the average price target is $ The highest price target for MRSN is $ Get Mersana Therapeutics Inc (MRSN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
MRSN Analyst Price Target ; High · ; Average · ; Low · View Mersana Therapeutics, Inc. MRSN stock quote prices, financial information, real-time forecasts, and company news from CNN. Based on short-term price targets offered by nine analysts, the average price target for Mersana Therapeutics, Inc. comes to $ The forecasts range from a. Is Mersana Therapeutics Stock Undervalued? The current Mersana Therapeutics [MRSN] share price is $ The Score for MRSN is 17, which is 66% below its. Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target.
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. Mersana Therapeutics (MRSN) stock price prediction is 0 USD. The Mersana Therapeutics stock forecast is 0 USD for September 08, Monday with technical. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. MRSN will report earnings. MRSN Analyst Price Target ; High · ; Average · ; Low · Bid Price and Ask Price. The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is. Mersana Therapeutics Inc (MRSN) has a Smart Score of 3 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom. Get Mersana Therapeutics Inc (MRSN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. MRSN | Complete Mersana Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Based on short-term price targets offered by nine analysts, the average price target for Mersana Therapeutics, Inc. comes to $ The forecasts range from a. Mersana Therapeutics Stock Prediction In , the Mersana Therapeutics stock will reach $ if it maintains its current year average growth rate. Is Mersana Therapeutics Stock Undervalued? The current Mersana Therapeutics [MRSN] share price is $ The Score for MRSN is 17, which is 66% below its. The average one-year price target for Mersana Therapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price. News · Mersana Therapeutics Is Maintained at Buy by Citigroup. Dow Jones · Citi Maintains Mersana Therapeutics(kondulaynen.ru) With Buy Rating, Maintains Target Price $5. MRSN's current price target is $ Learn why top analysts are making this stock forecast for Mersana Therapeutics at MarketBeat. Stock price target for Mersana Therapeutics, Inc. MRSN are on downside and Tomorrow Target 1, Tomorrow Target 2, Tomorrow Target 3. Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet needs. MERSANA THERAP. DL-, (0M4.F) stock forecast and price target · kondulaynen.runa Therapeutics, Inc. (%). At close: PM · Recommendation. According to analysts, MRSN price target is USD with a max estimate of USD and a min estimate of USD. Check if this forecast comes true in a year. Analysts average stock forecasts to be materialized ratio is % with an average time for these price targets to be met of days. Highest price target. The 6 analysts with month price forecasts for MRSN stock have an average target of , with a low estimate of and a high estimate of The average. Discover Mersana Therapeutics' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. On average, Wall Street analysts predict that Mersana Therapeutics's share price could reach $ by Aug 27, The average Mersana Therapeutics stock price. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mersana Therapeutics. Last Price. US$ ; Market Cap. US$m ; 7D. % ; 1Y. % ; Updated. 06 Sep, future price: according to them, MRSN price has a max estimate of USD and a min estimate of USD. Watch MRSN chart and read a more detailed Mersana. The average price target is $ with a high estimate of $8 and a low estimate of $3. Sign in to your SmartPortfolio to see more analyst recommendations. View Mersana Therapeutics, Inc. MRSN stock quote prices, financial information, real-time forecasts, and company news from CNN.
Cnq Stock Tsx | 35 Mbps Internet Speed